ARID1A and ovarian serous carcinoma: This may explain the paradox of why tumours with high genomic instability, such as high-grade serous ovarian carcinoma (HGSOC), have a low prevalence of ARID1A (Figure 5), as loss of the ARID1A-BAF complex would render these tumours non-viable.